Relevance of Sp binding site polymorphism in WWOX for treatment outcome in pancreatic cancer
A genome-wide association study (GWAS) suggested inherited genetic single-nucleotide polymorphisms (SNPs) affecting overall survival (OS) in advanced pancreatic cancer. To identify robust clinical biomarkers, we tested the strongest reported candidate loci in an independent patient cohort, assessed...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
February 8, 2016
|
| In: |
Journal of the National Cancer Institute
Year: 2016, Volume: 108, Issue: 5 |
| ISSN: | 1460-2105 |
| DOI: | 10.1093/jnci/djv387 |
| Online Access: | Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1093/jnci/djv387 Verlag, lizenzpflichtig, Volltext: https://academic.oup.com/jnci/article/108/5/djv387/2412583 |
| Author Notes: | Markus A. Schirmer, Claudia M. Lüske, Sebastian Roppel, Alexander Schaudinn, Christian Zimmer, Ruben Pflüger, Martin Haubrock, Jacobe Rapp, Cenap Güngör, Maximilian Bockhorn, Thilo Hackert, Thomas Hank, Oliver Strobel, Jens Werner, Jakob R. Izbicki, Steven A. Johnsen, Jochen Gaedcke, Jürgen Brockmöller, B. Michael Ghadimi |
| Summary: | A genome-wide association study (GWAS) suggested inherited genetic single-nucleotide polymorphisms (SNPs) affecting overall survival (OS) in advanced pancreatic cancer. To identify robust clinical biomarkers, we tested the strongest reported candidate loci in an independent patient cohort, assessed cellular drug sensitivity, and evaluated molecular effects. |
|---|---|
| Item Description: | Gesehen am 14.05.2020 |
| Physical Description: | Online Resource |
| ISSN: | 1460-2105 |
| DOI: | 10.1093/jnci/djv387 |